CYTOKINETICS INC (CYTK)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenues | 66,769 | 1,579 | 463 | |
| Research and development | 112,554 | 99,841 | 84,612 | |
| General and administrative | 65,721 | 57,369 | 56,652 | |
| Total operating expenses | 178,275 | 157,210 | 141,264 | |
| Operating loss | -111,506 | -155,631 | -140,801 | |
| Interest and other income, net | 13,001 | 13,701 | 17,054 | |
| Change in fair value of liabilities related to rpi transactions | -14,600 | 3,900 | -15,200 | |
| Interest expense | 11,084 | - | 8,928 | |
| Change in fair value of derivative liabilities | 3,000 | -400 | 700 | |
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | 13,181 | 14,078 | 13,370 | |
| Interest and other expense, net | - | 8,868 | - | |
| Net loss | -134,370 | -161,376 | -160,545 | |
| Unrealized loss on available-for-sale securities, net | -851 | -541 | 6,535 | |
| Foreign currency translation adjustments | -852 | -312 | -126 | |
| Comprehensive loss | -136,073 | -162,229 | -154,136 | |
| Earnings per share, basic, total | -1.12 | -1.36 | -1.36 | |
| Earnings per share, diluted, total | -1.12 | -1.36 | -1.36 | |
| Weighted average number of shares outstanding, basic, total | 119,457 | 118,496 | 117,685 | |
| Weighted average number of shares outstanding, diluted, total | 119,457 | 118,496 | 117,685 | |